Search Results - "Colvin, Brian"

Why we do not need a Hippocratic Oath by Colvin, Brian T

Get full text

The Pastoral Pool: an evaluation of a new system of pastoral care provision by Sayer, Melissa M, Colvin, Brian T, Wood, Diana F

“…Context  Medical students experience significant stress and stress‐related problems. The benefits of support during training are described in this paper…”
Get full text

Adam Lothian Turnbull by Barnes, Colin G, Colvin, Brian T

“…After qualifying in 1947 he became house physician to the medical unit, directed by Clifford Wilson, which included responsibility for the rheumatology beds…”
Get full text

Improving haemophilia patient care through sharing best practice by de Moerloose, Philippe, Arnberg, Daniel, O'Mahony, Brian, Colvin, Brian

“…At the 2014 Annual Congress of the European Haemophilia Consortium (EHC) held in Belfast, Northern Ireland, Pfizer initiated and funded a satellite symposium…”
Get full text

Pfizer-sponsored satellite symposium at the European Haemophilia Consortium (EHC) congress. Understanding health outcomes: focus on haemophilia by Colvin, Brian, Dolan, Gerry, Martinoli, Carlo, O'Mahony, Brian

“…At the 25th Annual European Haemophilia Consortium (EHC) Congress held in Prague, Czech Republic, in October 2012, Pfizer sponsored a satellite symposium…”
Get full text

Disorders of haemostasis by Colvin, Brian T

“…Many conditions adversely affect the delicate balance between the maintenance of blood flow and the ability to form localized clots to limit blood loss…”
Get full text

The Clinical Ethics Committee at Barts and the London NHS Trust: rationale, achievements, and difficulties by Doyal, Len, Colvin, Brian

“…Clinical ethics committees (CECs) have long been a feature of hospital medicine in North America. Their ethico-legal functions include the formulation of…”
Get full text

Creation of a novel donor splice site in intron 1 of the factor VIII gene leads to activation of a 191 bp cryptic exon in two haemophilia A patients by Bagnall, Richard D., Waseem, Naushin H., Green, Peter M., Colvin, Brian, Lee, Christine, Giannelli, Francesco

“…We have constructed a confidential U.K. database of haemophilia A mutations and pedigrees by characterizing the gene defect of one index patient in each U.K…”
Get full text

A 7-year analysis of anti-Gag (p17 and p24) antibodies in HIV-1-seropositive patients with haemophilia: immunoglobulin G titre and avidity are early predictors of clinical course by Chargelegue, D, Colvin, B T, O'Toole, C M

“…To study the humoral immune response to HIV-1 p17 and p24 Gag proteins longitudinally and assess any prognostic value. Fifteen HIV-1 infected patients with…”
Get more information

The Absence or Loss of Antibodies of High Affinity to Human Immunodeficiency Virus (HIV) Is Associated with Disease Progression in HIV-1-Infected Patients by Chargelegue, Daniel, Stanley, Carolynne M., O'Toole, Carol M., Colvin, Brian T., Steward, Michael W.

“…Our data and that of Brostroem et al. indicate early that HIV-specific antibodies of high affinity are maintained only in long-term asymptomatic patients (…”
Get full text

Decline in CTL and antibody responses to HIV-1 p17 and p24 antigens in HIV-1-infected hemophiliacs irrespective of disease progression. A 5-year follow-up study by O'Toole, C M, Lowdell, M W, Chargelegue, D, Colvin, B T

“…CTL and antibody responses to HIV-1 p17 and p24 antigens were monitored from 1986-1991, in 4 hemophiliacs. The patients had been infected with HIV-1 between…”
Get more information

So you want to train in haematology by Colvin, B T

Get more information

Role of plasma-exchange in the management of patients with factor VIII inhibitors by Colvin, B T

“…Plasma-exchange is one of many treatments available for the prevention and management of hemorrhage in patients with factor VIII inhibitors. Details of…”
Get more information

Heat-treated NHS factor VIII concentrate in the United Kingdom--a preliminary study by Colvin, B T, Ainsworth, M, Machin, S J, Mackie, I J, Smith, J K, Winkelman, L, Haddon, M E

“…Three patients who have been given intermediate purity NHS heat-treated factor VIII concentrate have been followed prospectively for 7-10 months. None had…”
Get more information